Cart
sales@molnova.com
VY-3-135
CAS No. 1824637-41-3
VY-3-135( —— )
Catalog No. M28868 CAS No. 1824637-41-3
VY-3-135 is a metastasis inhibitor and an acetyl-?CoA synthetase 2 (ACSS2) modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | Get Quote |
|
| 10MG | 295 | Get Quote |
|
| 25MG | 502 | Get Quote |
|
| 50MG | 709 | Get Quote |
|
| 100MG | 1008 | Get Quote |
|
| 500MG | 2007 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVY-3-135
-
NoteResearch use only, not for human use.
-
Brief DescriptionVY-3-135 is a metastasis inhibitor and an acetyl-?CoA synthetase 2 (ACSS2) modulator.
-
DescriptionVY-3-135 is a metastasis inhibitor and an acetyl-?CoA synthetase 2 (ACSS2) modulator.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetFatty Acid Synthase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1824637-41-3
-
Formula Weight429.51
-
Molecular FormulaC26H27N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (116.41 mM)
-
SMILESCCn1c(cc(cc2)C(NC[C@@H](C)O)=O)c2nc1C(c1ccccc1)(c1ccccc1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hussein H, Abu-Zeid K M. 2-hydrazinopyrimidines as precursors for azolopyri-midìnes and pyrimidotriazines expected antimicrobial activity[J]. Egyptian Journal of Chemistry, 2007, 50(6):725-737.
molnova catalog
related products
-
Orlistat
Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.
-
Trimetazidine dihydr...
Trimetazidine dihydrochloride is a drug for angina pectoris. Trimetazidine is the first cytoprotective anti-ischemic agent.
-
UCM05
UCM05 (G28UCM) is a potent inhibitor of fatty acid synthase (FASN) with efficacy against HER2+ breast cancer xenografts, including cell lines resistant to anti-HER2 drugs .
